Parker Bioscience Expands UK Facilities
Parker Bioscience will expand laboratory, cleanroom, office, and warehouse facilities at its Birtley, UK manufacturing site.
Parker Bioscience will undertake a multi-million-dollar phased-investment program throughout the remainder of 2018 to expand laboratory, cleanroom, office, and warehouse facilities at its Birtley, UK manufacturing site, the company announced on May 16, 2018.
In 2017, it was announced that the Birtley facility would start the manufacture of the company’s automated bioprocessing systems, complementing existing production at its site in California. In 2016, the company introduced a new ISO Class 7 cleanroom at the facility, from which Parker Bioscience is now producing single-use manifolds incorporating tubing, bioprocess containers, filters, sensors, and other components for use in the bioprocessing industry.
The increased investment will enable Parker Bioscience to service its European biopharmaceutical markets more effectively by shortening the supply chain.
Source: Parker Bioscience
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
